Effect of a Pomegranate Extract on Cardiovascular Risk Markers in Overweight Healthy Subjects

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

December 31, 2014

Conditions
Overweight
Interventions
DIETARY_SUPPLEMENT

Pomegranate extract-first dose-Group A

Group A will consume 1 daily capsule of pomegranate extract for 3 weeks

DIETARY_SUPPLEMENT

Placebo-first dose-Group B

Group B will consume 1 daily capsules of placebo for 3 weeks.

DIETARY_SUPPLEMENT

Pomegranate extract-first dose-Group B

After 3 weeks of washout, group B will consume 1 daily capsule of pomegranate extract for 3 weeks.

DIETARY_SUPPLEMENT

Placebo-first dose-Group A

After 3 weeks of washout, group A will consume 1 daily capsule of placebo for 3 weeks.

DIETARY_SUPPLEMENT

Pomegranate extract-second dose-Group A

After 3 weeks of washout, group A will consume 4 daily capsules of pomegranate extract for 3 weeks.

DIETARY_SUPPLEMENT

Placebo-second dose-Group B

After 3 weeks of washout, group B will consume 4 daily capsules of placebo for 3 weeks.

DIETARY_SUPPLEMENT

Pomegranate extract-second dose-Group B

After 3 weeks of washout, group B will consume 4 daily capsules of pomegranate extract for 3 weeks.

DIETARY_SUPPLEMENT

Placebo-second dose-Group A

After 3 weeks of washout, group A will consume 4 daily capsules of placebo for 3 weeks.

Trial Locations (1)

30107

UCAM (San Antonio Catholic University from Murcia), Murcia

All Listed Sponsors
collaborator

Universidad Católica San Antonio de Murcia

OTHER

collaborator

The Scientific and Technological Research Council of Turkey

OTHER

lead

National Research Council, Spain

OTHER_GOV